On February 24, 2020 Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company that is developing a new class of drugs known as DARPin therapies, reported that senior management will present at two upcoming healthcare investor conferences (Press release, Molecular Partners, FEB 24, 2020, View Source [SID1234554674]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Presentation Details:
Event: SVB Leerink 9th Annual Global Healthcare Conference
Date/Time: Wednesday, February 26, 2020 at 1:30 p.m. ET (7:30 p.m. CET)
Location: New York, NY

Event: Cowen & Co. 40th Annual Healthcare Conference
Date/Time: Tuesday, March 3, 2020 at 8:00 a.m. ET (2:00 p.m. CET)
Location: Boston, MA

A live webcast for the SVB Leerink and Cowen & Co. conference presentations may be accessed on the Investors/Media page of the Company’s website at www.molecularpartners.com. A replay of each webcast will be available shortly after the event on the Molecular Partners website.